Form S-4 - Registration of securities, business combinations:
SEC Accession No. 0001193125-23-234499
Filing Date
2023-09-13
Accepted
2023-09-13 17:20:05
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-4 d508095ds4.htm S-4 2807256
2 EX-8.1 d508095dex81.htm EX-8.1 10872
3 EX-23.1 d508095dex231.htm EX-23.1 1638
4 EX-23.2 d508095dex232.htm EX-23.2 2561
5 EX-99.1 d508095dex991.htm EX-99.1 4493
6 EX-99.2 d508095dex992.htm EX-99.2 2195
7 EX-FILING FEES d508095dexfilingfees.htm EX-FILING FEES 23994
8 GRAPHIC g508095g01a03.jpg GRAPHIC 55381
9 GRAPHIC g508095g61h22.jpg GRAPHIC 24732
10 GRAPHIC g508095g98w58.jpg GRAPHIC 27080
11 GRAPHIC g508095goodwin.jpg GRAPHIC 3592
  Complete submission text file 0001193125-23-234499.txt   3004279
Mailing Address 700 SAGINAW DR REDWOOD CITY CA 94063
Business Address 700 SAGINAW DR REDWOOD CITY CA 94063 415-766-3638
Revolution Medicines, Inc. (Filer) CIK: 0001628171 (see all company filings)

EIN.: 472029180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-4 | Act: 33 | File No.: 333-274499 | Film No.: 231253513
SIC: 2836 Biological Products, (No Diagnostic Substances)